Newsom Leverages Trump Gaffe to Spotlight Federal Cannabis Reform

California Governor Gavin Newsom capitalized on President Trump's verbal mistake during Oval Office remarks, where Trump incorrectly referred to the Democrat as "president of the United States." Newsom responded by jokingly declaring cannabis federally legal among his first "presidential" acts, highlighting the stark divide between state and federal marijuana policy that continues to constrain industry growth.

The exchange underscores the regulatory uncertainty that weighs on cannabis valuations across public markets. While 38 states have legalized medical marijuana and 21 permit recreational use, federal prohibition under the Controlled Substances Act creates banking restrictions, tax burdens, and interstate commerce limitations that suppress sector multiples compared to traditional consumer goods companies.

Multi-state operators like Curaleaf (CURLF), Green Thumb Industries (GTBIF), and Trulieve (TCNNF) trade at significant discounts to mainstream retail despite generating billions in combined revenue. Federal legalization would eliminate the 280E tax provision that prevents cannabis companies from deducting standard business expenses, potentially boosting margins by 15-25% across the sector.

Newsom's quip reflects California's outsized influence on national cannabis policy discussions. The state generates over $5 billion in annual cannabis sales, representing roughly 25% of the U.S. legal market. California's regulatory framework and market dynamics often serve as templates for emerging state programs, making the governor's cannabis positions particularly relevant for industry stakeholders.

The political theater occurs as Congress considers incremental reform measures like the SAFE Banking Act, which would provide financial services access to state-legal cannabis businesses. While comprehensive federal legalization remains unlikely in the near term, banking reform could unlock institutional investment and reduce operational costs that currently handicap public cannabis companies against black market competitors.